[DOI] [PMC free article] [PubMed] [Google Scholar] Kellaher C (2022) Eli Lillys Tirzepatide Meets Main Endpoints in Phase 3 Obesity Study, MarketWatch
Stay informed, explore current alternatives, and connect with Klinic to ensure you're prepared when potential treatments like Retatrutide become available
And the reasons behind it reveal important differences between these two GLP-1 medications that affect how you approach the transition
Insured patients also complete monthly dietitian sessions for accountability, while labs and renewals are managed individually by the care team
Whether you are interested in FDA-approved Zepbound, compounded tirzepatide, or another physician-guided weight loss program, our goal is to help you find a safe, personalized option based on your health history, goals, eligibility, and provider recommendations
doi: 10.1096/fj.14-265983 39 GreenhillC